8-K: Akoustis Technologies Faces Nasdaq Delisting After Share Price Plunge

Akoustis Technologies has received a delisting notice from Nasdaq after its share price fell below $0.10, and the company plans to appeal the decision.

Summary

• Akoustis Technologies received a notice from Nasdaq on August 19, 2024, stating that its common stock will be delisted due to the share price closing at $0.10 or less for ten consecutive trading days.
• This delisting notice follows a previous notification in October 2023 regarding non-compliance with the $1.00 minimum bid price requirement.
• The company was initially given until April 22, 2024, to regain compliance, which was then extended to October 21, 2024.
• Akoustis intends to request a hearing before a Nasdaq Hearings Panel to appeal the delisting determination.
• The hearing request will temporarily halt any delisting action while the appeal is pending.
• There is no guarantee that the panel will grant the company any further compliance period or that the company will regain compliance with Nasdaq listing requirements.
• The company is considering a reverse stock split to regain compliance, subject to stockholder approval at the 2024 annual meeting.

Sentiment

Score: 2

Explanation: The document conveys a negative sentiment due to the delisting notice and the uncertainty surrounding the company's ability to regain compliance. The risk of delisting is a significant concern for investors.

Positives

• The company is taking steps to appeal the delisting decision by requesting a hearing.
• The hearing request will automatically stay any suspension or delisting action pending the hearing.
• Akoustis is exploring options to regain compliance, including a potential reverse stock split.

Negatives

• The company's stock price has fallen below $0.10, triggering the delisting notice.
• Akoustis has failed to regain compliance with the $1.00 minimum bid price requirement despite an initial 180-day compliance period and a subsequent extension.
• There is no assurance that the company will be granted any further compliance period or that it will regain compliance with Nasdaq listing requirements.
• Delisting from Nasdaq would materially and adversely affect the company's ability to raise capital and its financial condition.

Risks

• There is a risk that the Nasdaq Hearings Panel will not grant the company any further compliance period.
• The company may not be able to regain compliance with the minimum bid price requirement.
• Delisting from Nasdaq could significantly impact the company's ability to raise capital and its overall financial health.
• The process of appealing the delisting and seeking compliance may divert management's attention and resources.

Future Outlook

The company is focused on regaining compliance with Nasdaq listing rules, including a potential reverse stock split, but there is no guarantee of success. The company is also monitoring the closing bid price of its common stock and will consider options to regain compliance with the Minimum Bid Price Requirement.

Management Comments

• The company intends to timely request a hearing before a Nasdaq Hearings Panel to appeal the Delisting Determination.
• The company is monitoring the closing bid price of its common stock and will consider options to regain compliance with the Minimum Bid Price Requirement, including seeking stockholder approval for the implementation of a reverse stock split of the Company's common stock at its 2024 annual meeting of stockholders.

Industry Context

This delisting notice highlights the challenges faced by companies with low stock prices, particularly in volatile market conditions. It is not uncommon for companies to struggle with maintaining compliance with minimum bid price requirements, especially in the technology sector where valuations can fluctuate significantly.

Comparison to Industry Standards

• Many small-cap technology companies face similar challenges with maintaining Nasdaq listing compliance, particularly during periods of market volatility.
• A reverse stock split is a common strategy used by companies to regain compliance with minimum bid price requirements, although it does not always guarantee long-term success.
• Companies like Akoustis, which are in the development and early commercialization phase, often experience stock price volatility due to the inherent risks associated with their business model.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is delisted.
• Employees may experience uncertainty about the company's future.
• The company's ability to raise capital may be significantly impacted, affecting its growth prospects.

Next Steps

• The company will request a hearing before a Nasdaq Hearings Panel to appeal the delisting determination.
• The company will monitor the closing bid price of its common stock.
• The company will consider options to regain compliance, including a potential reverse stock split at the 2024 annual meeting of stockholders.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, compliance, reverse stock split, hearing, AKTS, stock price